Would you cover presacral lymph-nodes in endometrial cancer patients with locally advanced disease (IIIC2 disease) who received neo-adjuvant chemotherapy prior to resection with no residual disease on pathology?  


Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at West Virginia University
No data either way but the morbidity is low and a ...
Sign in or Register to read more